Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects

NCT06280534 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: Test drug XT1061 capsules and placebo,Single dose group
DRUG: Test drug XT1061 capsules and placebo，Multiple dosing group
DRUG: Test drug XT1061 capsules and placebo，Food Impact Group

Sponsor

Xi'an Xintong Pharmaceutical Research Co.,Ltd.